Life Sciences Managing Director

Life Sciences - Managing Director

Managing Directors at CFGI serve as trusted advisors to senior finance executives and provide leadership across client delivery, relationship development, business development, and team growth.

This Managing Director will help expand CFGI’s Finance & Accounting Advisory presence within the life sciences sector. The role will support biotechnology, pharmaceutical, medical device, diagnostics, and other life sciences organizations as they navigate complex accounting, financial reporting, transactions, capital-markets activity, and operational challenges.

Take ownership of your career at CFGI:

• Advise executives at emerging, growth-stage, commercial, and publicly traded life sciences companies.
• Lead complex accounting, financial reporting, transaction, and operational advisory engagements.
• Develop meaningful relationships across the life sciences business community.
• Help build and expand CFGI’s life sciences market presence.
• Lead and develop high-performing teams of accounting and advisory professionals.
• Collaborate with professionals across CFGI’s broader accounting, finance, transaction, technology, data, tax, valuation, and risk capabilities.
• Make a measurable impact on clients while contributing to the continued growth of CFGI.

What you might expect:

• Serve as a trusted advisor to CFOs, Chief Accounting Officers, Controllers, Audit Committees, Boards of Directors, and other senior stakeholders.

• Lead complex technical accounting, financial reporting, transaction support, SEC reporting, and operational accounting engagements.

• Advise life sciences companies across different stages of development, including venture-backed, clinical-stage, pre-commercial, commercial-stage, and publicly traded organizations.

• Help clients evaluate and resolve accounting matters involving:

• • • Research and development activities.
    • Clinical trial and contract research organization accruals.
    • Contract development and manufacturing arrangements.
    • Collaboration, licensing, co-development, royalty, and milestone agreements.
    • Revenue recognition and commercialization arrangements.
    • Stock-based compensation and equity transactions.
    • Debt, convertible instruments, warrants, and preferred equity.
    • Business combinations, asset acquisitions, and in-process research and development.
    • Consolidation, impairment, leases, and other complex U.S. GAAP matters.